Scientists take 'very positive step' towards universal cancer vaccine
Genetic breakthrough sees patients' immune systems tricked into attacking tumours
Scientists have taken a "very positive step" towards creating a universal vaccine against cancer, say experts.
Reported in the journal Nature, the potential new therapy involves patients' immune systems attacking tumours as if they were viruses.
Pieces of cancer's genetic RNA code were placed into nanoparticles of fat and injected into three patients in the advanced stage of the disease. In response, the immune systems produced cells designed to specifically attack the disease.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The vaccine was also found to be effective in fighting "aggressively growing" tumours in mice, say the researchers, who were led by Professor Ugur Sahin from Johannes Gutenberg University in Germany.
"The vaccines are fast and inexpensive to produce and virtually any tumour antigen can be encoded by RNA," said Sahin.
"The approach introduced here may be regarded as a universally applicable novel vaccine class for cancer immunotherapy."
Dr Helen Rippon, the chief executive of Worldwide Cancer Research, described it as a "very positive step forwards towards the global goal of a 'universal cancer vaccine'".
She added: "We know the immune system has great potential to be manipulated and reactivated to fight cancer cells. These are exciting and novel results, showing the promise of an RNA nanoparticle vaccine to do just that."
The genetic code could be "programmed" for any cancer, says the Daily Telegraph. "All doctors would need is the genetic profile of the tumour to make a custom-made vaccine which, as well as fighting the disease, would prevent it ever returning."
While heralding the breakthrough, Dr Aine McCarthy, Cancer Research UK's senior science information officer, warned that larger clinical trials were needed to confirm that it "works and is safe. More research is also needed to determine if it can be used to treat other types of cancer, she said.
It is "still very early days", says ScienceAlert, but we have "another reason to feel hopeful about the future of cancer treatment – and that's always a good thing".
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The issue of women and conscription
Under the radar Ukraine military adviser hints at widening draft to women, as other countries weigh defence options amid global insecurity
By Harriet Marsden, The Week UK Published
-
AI is causing concern among the LGBTQ community
In the Spotlight One critic believes that AI will 'always fail LGBTQ people'
By Justin Klawans, The Week US Published
-
'Modern presidents exercise power undreamed of by the Founding Fathers'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance
By Chas Newkey-Burden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
What to say to someone who has cancer
The Explainer Saying something is better than nothing but there are some things to avoid too
By Chas Newkey-Burden, The Week UK Published